Corpus Intelligence IC Memo — GREAT PLAINS HEALTH 2026-04-26 03:51 UTC
IC Memo — GREAT PLAINS HEALTH
Investment Committee Memorandum | NE | 96 beds | Grade C | EBITDA uplift $19.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GREAT PLAINS HEALTH

CCN 280065 | nan, NE | 96 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

GREAT PLAINS HEALTH is a 96-bed suburban community hospital in nan, NE with $268.8M in net patient revenue and a 3.9% operating margin. The hospital serves a payer mix of 54.0% Medicare, 15.7% Medicaid, and 30.3% commercial.

Thesis: Turnaround. Our ML models identify $19.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.9% to 11.3% (+736bps).

Net Revenue HCRIS$268.8M
Current EBITDA COMPUTED$10.5M
Operating Margin COMPUTED3.9%
Occupancy HCRIS52.7%
Revenue / Bed COMPUTED$2.8M
Net-to-Gross HCRIS38.6%
Distress Probability ML50.1%

2. Market Context & Competitive Position

98
NE Hospitals
-6.3%
State Median Margin
21
Comparable Hospitals

NE has 98 Medicare-certified hospitals with a median operating margin of -6.3%. The target's margin of 3.9% places it above the state median. Among 21 size-comparable peers (48-192 beds), the median margin is -8.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (48-192), prioritizing same-state peers. 21 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GREAT PLAINS HEALTH (Target)NE96$268.8M3.9%
CHILDRENS HOSPITAL & MEDICAL CNE186$501.1M-10.3%
REGIONAL WEST MEDICAL CENTERNE122$218.4M-12.9%
CHI HEALTH LAKESIDENE125$200.3M15.3%
MARY LANNING MEMORIAL HOSPITALNE97$200.0M-8.9%
FAITH REGIONAL HEALTH SERVICESNE122$198.1M10.1%
CHI HEALTH IMMANUELNE177$187.9M-8.8%
MADONNA REHABILITATION LTC HOSNE77$177.1M-8.8%
MADONNA REHAB OMAHA LTC HOSPITNE67$177.1M-8.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.6M+210bp18mo
Cost to Collect4.5%2.5%$5.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.3M+122bp9mo
Clean Claim Rate88.0%96.0%$172K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.6M
Cost to Collect
$5.4M
Denial Rate Reduction
$5.3M
A/R Days Reduction
$3.3M
Clean Claim Rate
$172K
Total EBITDA Uplift$19.8M
Current EBITDA$10.5M
+ RCM Uplift+$19.8M
Pro Forma EBITDA$30.3M
Current Margin3.9%
Pro Forma Margin11.3%
WC Released (1x)$10.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$16.1M$267.0M16.56x75.3%
Base (11x exit)10.0x11.0x$16.1M$299.0M18.54x79.3%
Bull Case9.0x11.0x$14.5M$369.5M25.46x91.1%
Bull (12x exit)9.0x12.0x$14.5M$407.4M28.07x94.8%
Bear Case11.0x10.0x$17.7M$162.8M9.18x55.8%
Bear (11x exit)11.0x11.0x$17.7M$184.9M10.42x59.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 21 hospitals with 48-192 beds
  • Same-state prioritization (n=22)
  • Comp margins: P25=-10.5% / P50=-8.8% / P75=-1.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.